|
Commissioned
Projects
RFCID supports studies
commissioned by the FHB as well as those initiated by individual investigators
to address health problems, fill scientific gaps and respond to public
threats or needs. The cost ceiling is determined by the Research Council
based on the size and nature of the proposed research activities.
Four commissioned
projects have been approved:
-
The University
of Hong Kong: $30 million approved to undertake a portfolio of basic
laboratory, epidemiology and public health research in emerging infectious
diseases, and to upgrade its Bio-safety Level 3 laboratory with enhancement
for animal experimentation.
-
The Chinese University
of Hong Kong: $25 million approved to undertake a portfolio of clinical
trial and public health research in emerging infectious diseases.
-
The Hospital Authority
Consortium (HA together with the Hong Kong Polytechnic University,
the Hong Kong University of Science and Technology and the University
of Hong Kong): $8.2 million approved to undertake a portfolio of research
on nosocomial infection and long-term follow-up of SARS patients.
-
The Centre for
Health Protection: Funding details are being finalised. $30 million
has been earmarked over a 5-year period to conduct a portfolio of
studies on cost-effectiveness of primary prevention of infections;
surveillance, epidemiology and public health control of infections
with a regional (cross-border) significance; and prevention of spread
of healthcare-associated infections in community settings
For the commissioned
projects, information on the project title, applicant(s), and administering
institution(s) is available on the List
of RFCID - Commissioned Projects. Upon project completion, dissemination
reports will be made available for public access on this page.
|
Research Fund for the Control of Infectious Diseases 
|